NET PROFIT (x1000 EUR)
EMPLOYEES
Pharmnovo AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/06 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
127
|
10 |
| Earnings before taxes |
-2,111
|
-6,205
|
-2,486 |
| EBITDA |
-2,147
|
-6,086
|
-2,473 |
| Total assets |
1,409
|
2,173
|
2,532 |
| Current assets |
1,401
|
2,165
|
2,520 |
| Current liabilities |
346
|
314
|
244 |
| Equity capital |
1,059
|
1,855
|
2,284 |
| - share capital |
50
|
37
|
32 |
| Employees (average) |
4
|
3
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/06 |
| Solvency |
75.2%
|
85.4%
|
90.2% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-149.8%
|
-279.7%
|
-97.8% |
| Current ratio |
404.9%
|
689.5%
|
1032.8% |
| Return on equity (ROE) |
-199.3%
|
-334.5%
|
-108.8% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
1
|
2
|
0 |
| Chg. No. of employees % |
33%
|
200%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.